MERCK SHARP & DOHME CORP. EISAI
1Patents
0Active
1Granted
16Portfolio score
Filing activity: Mar 3, 2016 → Mar 3, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11147806B2 | Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.